Ultrasound and alendronate: new tools for osteoporosis screening and treatment.
Office-based physicians can now use ultrasonography of the heel to screen for osteoporosis and estimate the risk of fractures. In treating osteoporosis, alendronate has been shown to increase bone mineral density and to decrease the incidence of fractures.
Tonino
R P
RP
University of Vermont College of Medicine, USA.
D015502:Absorptiometry, Photon; D000368:Aged; D019386:Alendronate / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use; D011379:Prognosis; D020849:Raloxifene Hydrochloride; D016896:Treatment Outcome; D014463:Ultrasonography; D014807:Vitamin D / Q000627:therapeutic use
D004965:Estrogen Antagonists; D010880:Piperidines; D014807:Vitamin D; D020849:Raloxifene Hydrochloride; D002118:Calcium; D019386:Alendronate